In this study, we found that the mRNA level of AGPAT9 in MDA-MB-231 cells (highly invasive breast cancer cells) was significantly lower than in MCF7 cells (poorly invasive breast cancer cells) (–8.06-fold; Figure 1A). This evidence concerns the gene GPAT3 and breast carcinoma.